Cero Therapeutics Files 8-K with Corporate Updates
Ticker: CEROW · Form: 8-K · Filed: Apr 25, 2025 · CIK: 1870404
Sentiment: neutral
Topics: corporate-actions, filings, financials
TL;DR
Cero Therapeutics filed an 8-K on 4/25 for events on 4/22, including corporate docs and financials.
AI Summary
Cero Therapeutics Holdings, Inc. filed an 8-K on April 25, 2025, reporting events as of April 22, 2025. The filing indicates amendments to its Articles of Incorporation or Bylaws, a Regulation FD disclosure, and the filing of financial statements and exhibits. The company, formerly Phoenix Biotech Acquisition Corp., is incorporated in Delaware and operates in the biological products sector.
Why It Matters
This 8-K filing signals potential corporate structure changes or disclosures of material information, which could impact investor understanding of Cero Therapeutics' current standing and future direction.
Risk Assessment
Risk Level: low — The filing is a routine 8-K reporting corporate actions and financial statements, not indicating any immediate financial distress or significant negative events.
Key Players & Entities
- CERO THERAPEUTICS HOLDINGS, INC. (company) — Registrant
- Phoenix Biotech Acquisition Corp. (company) — Former Company Name
- April 22, 2025 (date) — Date of earliest event reported
- April 25, 2025 (date) — Date of Report
FAQ
What specific amendments were made to Cero Therapeutics' Articles of Incorporation or Bylaws?
The filing indicates amendments were made, but the specific details of these amendments are not provided in the provided text.
What is the nature of the Regulation FD disclosure mentioned in the filing?
The provided text states that a Regulation FD Disclosure was made, but does not specify the content of this disclosure.
What financial statements and exhibits are being filed with this 8-K?
The filing mentions that Financial Statements and Exhibits are being filed, but the specific list or content is not detailed in the provided text.
When did Cero Therapeutics Holdings, Inc. change its name from Phoenix Biotech Acquisition Corp.?
The date of the name change from Phoenix Biotech Acquisition Corp. to Cero Therapeutics Holdings, Inc. was June 30, 2021.
What is Cero Therapeutics Holdings, Inc.'s Standard Industrial Classification (SIC) code and industry?
Cero Therapeutics Holdings, Inc. has a SIC code of 2836 and is classified under Biological Products (No Diagnostic Substances).
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 25, 2025 regarding CERO THERAPEUTICS HOLDINGS, INC. (CEROW).